Literature DB >> 8769756

1,25(OH)2D3 modulates intracellular Ca2+ and force generation in resistance arteries.

K Bian1, K Ishibashi, R D Bukoski.   

Abstract

The mechanism by which 1 alpha,25-dihydroxycholecalciferol [1,25(OH)2D3] enhances smooth muscle force generation was examined. Rats were injected on three mornings with 1,25(OH)2D3 (35 ng/100 g) or vehicle, and on the fourth morning mesenteric resistance arteries were isolated and used for simultaneous measurement of intracellular Ca2+ and force or myosin light chain phosphorylation. 1,25(OH)2D3 did not affect media thickness or wall-to-lumen ratio, but it increased basal intracellular Ca2+ (vehicle = 49.2 +/- 2.2 nM vs. 1,25(OH)2D3 = 65.9 +/- 4.0 nM, P < 0.05, n = 24-26 rats). 1,25(OH)2D3 enhanced the active stress and intracellular Ca2+ responses to increasing doses of norepinephrine, and the increases were normalized by verapamil (10 microM). In a second group of animals, 1,25(OH)2D3 significantly increased both basal intracellular Ca2+ and light chain phosphorylation and the active stress and Ca2+ mobilization responses to norepinephrine (10 microM). The hormone did not affect peak or steady-state light chain phosphorylation. Myofilament Ca2+ sensitivity, determined during stimulation with 2 microM norepinephrine, was depressed in vessels isolated from rats treated with 1,25(OH)2D3 [vehicle Ca2+ 50% effective dosé (ED50) = 82.7 +/- 3.8 nM vs. 1,25(OH)2D3 = 104.8 +/- 4.9 nM, P = 0.002]. We conclude that 1,25(OH)2D3 enhances resistance artery force generation by altering smooth muscle Ca2+ homeostasis, with effects on basal and verapamil-sensitive, agonist-induced Ca2+ mobilization.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8769756     DOI: 10.1152/ajpheart.1996.270.1.H230

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

1.  Common genetic variations in the vitamin D pathway in relation to blood pressure.

Authors:  Lu Wang; Audrey Chu; Julie E Buring; Paul M Ridker; Daniel I Chasman; Howard D Sesso
Journal:  Am J Hypertens       Date:  2014-03-31       Impact factor: 2.689

2.  Vitamin D insufficiency is associated with impaired vascular endothelial and smooth muscle function and hypertension in young rats.

Authors:  Marianne Tare; Sarah J Emmett; Harold A Coleman; Con Skordilis; Darryl W Eyles; Ruth Morley; Helena C Parkington
Journal:  J Physiol       Date:  2011-08-01       Impact factor: 5.182

3.  A prospective study of plasma vitamin D metabolites, vitamin D receptor gene polymorphisms, and risk of hypertension in men.

Authors:  Lu Wang; Jing Ma; Joann E Manson; Julie E Buring; J Michael Gaziano; Howard D Sesso
Journal:  Eur J Nutr       Date:  2012-12-21       Impact factor: 5.614

4.  Vitamin D induces increased systolic arterial pressure via vascular reactivity and mechanical properties.

Authors:  Priscila Portugal Dos Santos; Bruna Paola Murino Rafacho; Andréa de Freitas Gonçalves; Rodrigo Gibin Jaldin; Thiago Bruder do Nascimento; Marcondes Alves Barbosa Silva; Stêfany Bruno Assis Cau; Meliza Goi Roscani; Paula Schimdt Azevedo; Marcos Ferreira Minicucci; Rita de Cássia Tostes; Leonardo Antonio Memede Zornoff; Sergio Alberto Rupp de Paiva
Journal:  PLoS One       Date:  2014-06-12       Impact factor: 3.240

5.  Modulation of the sympathetic nervous system in youngsters by vitamin-D supplementation.

Authors:  Rune Tønnesen; Peter Schwarz; Peter Hovind; Lars Thorbjørn Jensen
Journal:  Physiol Rep       Date:  2018-04

6.  Vitamin D receptor genetic polymorphism is significantly associated with decreased risk of hypertension in a Chinese Han population.

Authors:  Jian Jia; Chong Shen; Lina Mao; Keming Yang; Chen Men; Yiyang Zhan
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-09-05       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.